Among patients who stopped taking tirzepatide, 31.0% doubled their weight loss after two years, 15.2% lost some additional weight, and 9.0% maintained their initial loss, with 55.2% in total maintaining or losing more weight
Clinical dosing programs in other drug areas show that at the intermediate dosage stage, 50% of patients experienced mild side effects
Cutting or crushing the tablet disrupts this formulation, reduces bioavailability, and creates unpredictable drug levels that compromise effectiveness
Video Games
Both plans include medication, provider visits, coaching, and shipping
Zoe Lees, PhD, a behavioral health researcher who studies the impact of these drugs on hormone balance, metabolism, and psychological health